|
|
Volumn 290, Issue 5492, 2000, Pages 721-724
|
|
Biomedicine: Combating Parkinson's disease - Step three
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOPAMINE;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
LEVODOPA;
CELL GROWTH;
DOPAMINERGIC SYSTEM;
GENE THERAPY;
HUMAN;
NEUROMODULATION;
NEUROTROPISM;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
SHORT SURVEY;
ANIMALS;
DISEASE MODELS, ANIMAL;
DOPAMINE;
GENE THERAPY;
GENETIC VECTORS;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
HUMANS;
LENTIVIRUS;
MACACA MULATTA;
NEOSTRIATUM;
NERVE DEGENERATION;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
NEURAL PATHWAYS;
NEURONS;
PARKINSON DISEASE;
PARKINSONIAN DISORDERS;
PSYCHOMOTOR PERFORMANCE;
SUBSTANTIA NIGRA;
TYROSINE 3-MONOOXYGENASE;
|
|
EID: 0034721731
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.290.5492.721 Document Type: Short Survey |
|
Times cited : (21)
|
|
References (15)
|
